Trial record 5 of 6 for:
"Phimosis"
Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision
This study is currently recruiting participants.
Verified June 2017 by Bryce Weber, Alberta Children's Hospital
Sponsor:
Alberta Children's Hospital
Information provided by (Responsible Party):
Bryce Weber, Alberta Children's Hospital
ClinicalTrials.gov Identifier:
NCT02973958
First received: November 18, 2016
Last updated: June 27, 2017
Last verified: June 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Circumcision is the most common surgical procedure performed by Pediatric Urologists. Ketorolac has been shown to have an efficacy similar to morphine in multi-modal analgesic regimens without the commonly associated adverse effects. This study aims to see if giving ketorolac during the operation will result in better pain control. We hypothesize that ketorolac will result in pain control similar to morphine with a lower incidence of side effects such as nausea and vomiting.
| Condition | Intervention | Phase |
|---|---|---|
| Pain, Postoperative Phimosis Paraphimosis Balanitis | Drug: Bupivacaine Drug: Sevoflurane Drug: Acetaminophen Drug: Ibuprofen Drug: Ketorolac | Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Outcomes Assessor Primary Purpose: Supportive Care |
| Official Title: | A Pilot Study Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision |
Resource links provided by NLM:
Further study details as provided by Bryce Weber, Alberta Children's Hospital:
Primary Outcome Measures:
- Post-operative pain [ Time Frame: Immediately following the procedure ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 15 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 30 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 45 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 60 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 90 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 120 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 150 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 180 minutes post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
- Post-operative pain [ Time Frame: 24 hours post-operatively ]Evaluated through the use of the Face, Legs, Activity, Cry, Consolability (FLACC) pain score or Wong-Baker FACES scale ascertained by a nurse or research assistant blinded to the anesthetic technique through telephone follow-up with parental input. The FLACC scale will be used in children who have difficulty verbalizing pain and in sleeping children (regardless of age) while the Wong-Baker FACES scale will be used in patients capable of self-assessment. Both scores are out of 10 and can be averaged together to quantify post-operative pain
Secondary Outcome Measures:
- Total ibuprofen consumption [ Time Frame: 24 hours post-operatively ]Evaluated and compiled through anesthesia notes, post-operative nursing care notes and parental telephone follow-up
- Total acetaminophen consumption [ Time Frame: 24 hours post-operatively ]Evaluated and compiled through anesthesia notes, post-operative nursing care notes and parental telephone follow-up
- Incidence of bleeding requiring medical attention [ Time Frame: Up to 2 weeks ]Bleeding events will be compiled through post-anesthetic care unit, surgical short stay unit, clinic and emergency department notes
| Estimated Enrollment: | 30 |
| Actual Study Start Date: | February 1, 2017 |
| Estimated Study Completion Date: | February 2018 |
| Estimated Primary Completion Date: | February 2018 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: No ketorolac
15 mg/kg oral dose of acetaminophen is administered prior to surgery. General anesthesia will be induced with sevoflurane via facemask. After establishing venous access, a laryngeal mask will be inserted, and anesthesia maintained with 1 minimum alveolar anesthetic concentration (MAC) of sevoflurane in oxygen/air 50/50 mixture. The DPNB nerve block is done using a 23 GA needle inserted below the Buck fascia. Once the needle tip is positioned appropriately and after a negative aspiration test, 0.2mL/kg (maximum 10mL) of 0.25% bupivacaine is injected in small aliquots, with intermittent aspiration throughout. In all patients, skin incision is performed at least 5 min after placement of the nerve block. Patients will be advised to take ibuprofen and acetaminophen post-operatively as needed.
|
Drug: Bupivacaine
See active comparator description
Other Name: Marcaine
Drug: Sevoflurane
See active comparator description
Other Names:
Drug: Acetaminophen
See active comparator description
Other Name: Tylenol
Drug: Ibuprofen
See active comparator description
Other Name: Advil
|
|
Experimental: Peri-operative ketorolac
Exactly same as the no ketorolac group except at the beginning of the circumcision, once the patient is asleep, patients in the perioperative ketorolac group will also receive a 0.5 mg/kg intravenous dose of ketorolac.
|
Drug: Bupivacaine
See active comparator description
Other Name: Marcaine
Drug: Sevoflurane
See active comparator description
Other Names:
Drug: Acetaminophen
See active comparator description
Other Name: Tylenol
Drug: Ibuprofen
See active comparator description
Other Name: Advil
Drug: Ketorolac
See experimental arm description
Other Name: Toradol
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | up to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- All children admitted for circumcision at the Alberta Children's Hospital
Exclusion Criteria:
- History of allergic reactions to local anesthetics or ketorolac
- Bleeding diatheses
- Coagulopathy
- Infection at the injection site.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02973958
Please refer to this study by its ClinicalTrials.gov identifier: NCT02973958
Contacts
| Contact: Bryce Weber, MD FRCSC | 5872276652 | bryce.weber@albertahealthservices.ca |
Locations
| Canada, Alberta | |
| Alberta Children's Hospital | Recruiting |
| Calgary, Alberta, Canada, T3B 6A8 | |
| Contact: Bryce Weber, MD FRCSC 587-227-6652 bryce.weber@albertahealthservices.ca | |
| Principal Investigator: Bryce Weber, MD | |
Sponsors and Collaborators
Alberta Children's Hospital
Investigators
| Principal Investigator: | Bryce Weber, MD FRCSC | Alberta Children's Hospital |
More Information
Additional Information:
Publications:
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics 4.4: 287-291, 2005
| Responsible Party: | Bryce Weber, Pediatric Urologist, Alberta Children's Hospital |
| ClinicalTrials.gov Identifier: | NCT02973958 History of Changes |
| Other Study ID Numbers: |
REB16-1876 |
| Study First Received: | November 18, 2016 |
| Last Updated: | June 27, 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | Yes | |
| Studies a U.S. FDA-regulated Device Product: | No | |
| Product Manufactured in and Exported from the U.S.: | Yes | |
Keywords provided by Bryce Weber, Alberta Children's Hospital:
|
Penis Pain Ketorolac Circumcision |
Additional relevant MeSH terms:
|
Phimosis Pain, Postoperative Balanitis Paraphimosis Pain Neurologic Manifestations Nervous System Diseases Postoperative Complications Pathologic Processes Signs and Symptoms Penile Diseases Genital Diseases, Male Bupivacaine Sevoflurane Acetaminophen |
Ibuprofen Ketorolac Ketorolac Tromethamine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Analgesics, Non-Narcotic Analgesics Antipyretics Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents Antirheumatic Agents |
ClinicalTrials.gov processed this record on July 14, 2017


IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
